-
-
-
-
-
-
-
Valneva SE (VALN) Reports FY22 Revenue of EUR 361.3M, Loss of EUR 143.3M, Guides FY23 Revenue of EUR 220M-260M
-
-
-
-
-
-
-
Pfizer (PFE) and Valneva (VALN) Initiate Phase 3 Study of VLA15
-
-
-
-
-
-
-
Valneva Reports Q1 2022 Results and Provides Corporate Updates
-
-
-
-
-
-
-
Dynavax Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Full Year 2022 Financial Guidance
-
-
-
-
-
-
-
PFIZER REPORTS THIRD-QUARTER 2021 RESULTS
-
-
-
-
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

